Skip to main content
SpringerLink
Log in

Generation and analysis of an androgen-responsive myoblast cell line indicates that androgens regulate myotube protein accretion

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Androgens have anabolic actions in skeletal muscle and could potentially act to: (a) increase proliferation of myoblasts; (b) delay differentiation to myotubes; and (c) induce protein accretion in post-proliferative myofibers. To identify the site of androgens action, we investigated the proliferative response of the C2C12 mouse myoblast cell line to testosterone and dihydrotestosterone (DHT) treatment. Neither androgens affected cell proliferation after up to 7 days treatment, nor was there a synergistic effect of androgens on the proliferative response of C2C12 cells to IGF-I treatment. However, proliferating C2C12 cells expressed 0.1% of the level of androgen receptor (AR) mRNA found in adult mouse gastrocnemius muscle (p<0.01). Therefore, we generated mouse C2C12 myoblast cell lines stably transfected with the mouse AR cDNA driven by the SV40 promoter (C2C12-AR). C2C12-AR cell proliferation, differentiation, and protein content were analyzed in response to androgen treatment. Our data demonstrated that androgen treatment does not alter either proliferation rate or differentiation rate of C2C12-AR cells. However, treatment of differentiated C2C12-AR myotubes with 100 nM DHT for 3 days caused a 20% increase in total protein content vs vehicle treatment (p<0.05). This effect was not observed in control C2C12 cells transfected with empty vector. These data suggest that androgens act via the AR to upregulate myotube protein content. This model cell line will be useful to further investigate the molecular mechanisms via which androgens regulate protein accretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. MacLean HE, Warne GL, Zajac JD. Localization of functional domains in the androgen receptor. J Steroid Biochem Mol Biol 1997, 62: 233–42.

    Article  PubMed  CAS  Google Scholar 

  2. Hiort O. Androgens and puberty. Best Pract Res Clin Endocrinol Metab 2002, 16: 31–41.

    Article  PubMed  CAS  Google Scholar 

  3. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996, 335: 1–7.

    Article  PubMed  CAS  Google Scholar 

  4. Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men—a clinical research center study. J Clin Endocrinol Metab 1996, 81: 3469–75.

    PubMed  CAS  Google Scholar 

  5. Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005, 90: 678–88.

    Article  PubMed  CAS  Google Scholar 

  6. Bhasin S, Storer TW, Berman N, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997, 82: 407–13.

    PubMed  CAS  Google Scholar 

  7. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996, 81: 4358–65.

    PubMed  CAS  Google Scholar 

  8. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999, 84: 2647–53.

    PubMed  CAS  Google Scholar 

  9. Ferrando AA, Sheffield-Moore M, Yeckel CW, et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002, 282: E601–7.

    PubMed  CAS  Google Scholar 

  10. Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 1989, 66: 498–503.

    PubMed  CAS  Google Scholar 

  11. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 2001, 281: E1172–81.

    PubMed  CAS  Google Scholar 

  12. Axell AM, MacLean HE, Plant DR, et al. Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Physiol Endocrinol Metab 2006, 291: E506–16.

    Article  PubMed  CAS  Google Scholar 

  13. Sheffield-Moore M, Urban RJ, Wolf SE, et al. Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. J Clin Endocrinol Metab 1999, 84: 2705–11.

    PubMed  CAS  Google Scholar 

  14. Mauras N, Hayes V, Welch S, et al. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998, 83: 1886–92.

    PubMed  CAS  Google Scholar 

  15. Joubert Y, Tobin C, Lebart MC. Testosterone-induced masculinization of the rat levator ani muscle during puberty. Dev Biol 1994, 162: 104–10.

    Article  PubMed  CAS  Google Scholar 

  16. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 2006, 91: 3024–33.

    Article  PubMed  CAS  Google Scholar 

  17. Benjamin CL, Jenster G, Piedrahita JA. Use of artificial androgen receptor coactivators to alter myoblast proliferation. J Steroid Biochem Mol Biol 2004, 91: 111–9.

    Article  PubMed  CAS  Google Scholar 

  18. Lee DK. Androgen receptor enhances myogenin expression and accelerates differentiation. Biochem Biophys Res Commun 2002, 294: 408–13.

    Article  PubMed  CAS  Google Scholar 

  19. Florini JR, Ewton DZ, Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 1996, 17: 481–517.

    PubMed  CAS  Google Scholar 

  20. Urban RJ, Bodenburg YH, Gilkison C, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 1995, 269: E820–6.

    PubMed  CAS  Google Scholar 

  21. Gayan-Ramirez G, Rollier H, Vanderhoydonc F, Verhoeven G, Gosselink R, Decramer M. Nandrolone decanoate does not enhance training effects but increases IGF-I mRNAin rat diaphragm. J Appl Physiol 2000, 88: 26–34.

    PubMed  CAS  Google Scholar 

  22. Sahlin L, Norstedt G, Eriksson H. Androgen regulation of the insulin-like growth factor-I and the estrogen receptor in rat uterus and liver. J Steroid Biochem Mol Biol 1994, 51: 57–66.

    Article  PubMed  CAS  Google Scholar 

  23. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. Testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab 1993, 77: 776–9.

    PubMed  CAS  Google Scholar 

  24. Veldhuis JD, Metzger DL, Martha PM Jr, et al. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 1997, 82: 3414–20.

    PubMed  CAS  Google Scholar 

  25. Giannoulis MG, Sonksen PH, Umpleby M, et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab 2006, 91: 477–84.

    Article  PubMed  CAS  Google Scholar 

  26. Thompson SH, Boxhorn LK, Kong WY, Allen RE. Trenbolone alters the responsiveness of skeletal muscle satellite cells to fibroblast growth factor and insulin-like growth factor I. Endocrinology 1989, 124: 2110–7.

    Article  PubMed  CAS  Google Scholar 

  27. Jones ME, Boon WC, Proietto J, Simpson ER. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 2006, 17: 55–64.

    Article  PubMed  CAS  Google Scholar 

  28. Matsumine H, Hirato K, Yanaihara T, Tamada T, Yoshida M. Aromatization by skeletal muscle. J Clin Endocrinol Metab 1986, 63: 717–20.

    Article  PubMed  CAS  Google Scholar 

  29. Glenmark B, Nilsson M, Gao H, Gustafsson JA, Dahlman-Wright K, Westerblad H. Difference in skeletal muscle function in males vs. females: role of estrogen receptor-β. Am J Physiol Endocrinol Metab 2004, 287: E1125–31.

    Article  PubMed  CAS  Google Scholar 

  30. van Heuvel M, Bosveld IJ, Luyten W, Trapman J, Zwarthoff EC. Transient expression of murine interferon-alpha genes in mouse and monkey cells. Gene 1986, 45: 159–65.

    Article  PubMed  Google Scholar 

  31. Notini AJ, McManus JF, Moore A, et al. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Miner Res 2007, 22: 347–56.

    Article  PubMed  CAS  Google Scholar 

  32. Notini AJ, Davey RA, McManus JF, Bate KL, Zajac JD. Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse model. J Mol Endocrinol 2005, 35: 547–55.

    Article  PubMed  CAS  Google Scholar 

  33. MacLean HE, Chiu WM, Ma C, et al. Afloxed allele of the androgen receptor gene causes hyperandrogenization in male mice. Physiol Genomics 2008, Jan 2; doi:10.1152/physiolgenomics.00260.2007.

  34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(ΔΔ-C(T)) Method. Methods 2001, 25: 402–8.

    Article  PubMed  CAS  Google Scholar 

  35. Janssen T, Darro F, Petein M, et al. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer 1996, 77: 144–9.

    Article  PubMed  CAS  Google Scholar 

  36. Sinha-Hikim I, Roth SM, Lee MI, Bhasin S. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 2003, 285: E197–205.

    PubMed  CAS  Google Scholar 

  37. Powers ML, Florini JR. A direct effect of testosterone on muscle cells in tissue culture. Endocrinology 1975, 97: 1043–7.

    Article  PubMed  CAS  Google Scholar 

  38. Kamanga-Sollo E, Pampusch MS, Xi G, White ME, Hathaway MR, Dayton WR. IGF-I mRNA levels in bovine satellite cell cultures: effects of fusion and anabolic steroid treatment. J Cell Physiol 2004, 201: 181–9.

    Article  PubMed  CAS  Google Scholar 

  39. Doumit ME, Cook DR, Merkel RA. Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro. Endocrinology 1996, 137: 1385–94.

    PubMed  CAS  Google Scholar 

  40. Ferrando AA, Tipton KD, Doyle D, Phillips SM, Cortiella J, Wolfe RR. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol 1998, 275: E864–71.

    PubMed  CAS  Google Scholar 

  41. Joubert Y, Tobin C. Testosterone treatment results in quiescent satellite cells being activated and recruited into cell cycle in rat levator ani muscle. Dev Biol 1995, 169: 286–94.

    Article  PubMed  CAS  Google Scholar 

  42. Kadi F, Eriksson A, Holmner S, Thornell LE. Effects of anabolic steroids on the muscle cells of strength-trained athletes. Med Sci Sports Exerc 1999, 31: 1528–34.

    Article  PubMed  CAS  Google Scholar 

  43. Chen Y, Zajac JD, MacLean HE. Androgen regulation of satellite cell function. J Endocrinol 2005, 186: 21–31.

    Article  PubMed  CAS  Google Scholar 

  44. Nnodim JO. Testosterone mediates satellite cell activation in denervated rat levator ani muscle. Anat Rec 2001, 263: 19–24.

    Article  PubMed  CAS  Google Scholar 

  45. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998, 8: 397–403.

    Article  PubMed  CAS  Google Scholar 

  46. Prescott J, Coetzee GA. Molecular chaperones throughout the life cycle of the androgen receptor. Cancer Lett 2006, 231: 12–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC 3084, Australia

    Y. Chen, N. K. L. Lee, J. D. Zajac & H. E. MacLean PhD

Authors
  1. Y. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. K. L. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. D. Zajac
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. E. MacLean PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. E. MacLean PhD.

Additional information

These authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Y., Lee, N.K.L., Zajac, J.D. et al. Generation and analysis of an androgen-responsive myoblast cell line indicates that androgens regulate myotube protein accretion. J Endocrinol Invest 31, 910–918 (2008). https://doi.org/10.1007/BF03346441

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346441

Key-words

Search

Navigation